ATO4AyobamiAkenroyeAyobami Akenroye, M.B.,Ch.B.90115Akenroye, AyobamiAsthmaPharmacoepidemiologyComparative Effectiveness ResearchMonoclonal AntibodiesBiological Response ModifiersCausal inference617/525-1300Assistant Professor of Medicinecatalyst:eCommonsLogineCommons Loginprns:coAuthorOfcoauthor ofprns:endDateend dateFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:principalInvestigatorNameprincipal investigator nameprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:startDatestart dateprns:trainingAtOrganizationeducational organizationprns:trainingLocationtraining locationprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:address2address line 2vivo:address3address line 3vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipvivo:degreeEarneddegree earnedDepartmentDivisionvivo:educationalTrainingeducation and trainingEducational Trainingvivo:freetextKeywordkeywordsGrantvivo:hasResearchArearesearch areasvivo:hasResearcherRoleresearch activitiesvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:majorFieldmajor field of degreevivo:personInPositionpositionsvivo:phoneNumberphonePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleResearcher Rolevivo:researcherRoleOfresearcher role ofvivo:roleContributesTocontributes tovivo:sponsorAwardIdsponsor award idURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson22711718Volpe D, Harrison S, Damian F, Rachh P, Kahlon PS, Morrissey L, Mack J, Akenroye A, Stack AMPediatricsImproving timeliness of antibiotic delivery for patients with fever and suspected neutropenia in a pediatric emergency department. Pediatrics. 2012 Jul; 130(1):e201-10.Pediatrics2012-06-18T00:00:002012Improving timeliness of antibiotic delivery for patients with fever and suspected neutropenia in a pediatric emergency department.D006967Disorders48210860.512122HypersensitivityD001688Chemicals & Drugs4858500.508467Biological ProductsD011657Disorders56820.924761Pulmonary EosinophiliaD001249Disorders114159500.259889AsthmaD018927Chemicals & Drugs2105330.688194Anti-Asthmatic AgentsMedicinePediatricsEmergency MedicinePulmonaryImmunologyChanning Division of Network MedicineBrigham and Women's HospitalBoston Children's HospitalMassachusetts General HospitalSTW1ScottWeissScott Tillman Weiss, M.D.42.33669100000000-71.1020890000000050689Weiss, ScottProfessor of Medicine1136selected publications6.100950.00352015150research areas2.375230.027641812coauthor of162.6319.8774260similar toEI1ElliotIsraelElliot Israel, M.D.42.33510370000000-71.1061649000000011018Israel, ElliotProfessor of MedicineCAC9CarlosCamargoCarlos Arturo Camargo, Jr., Dr.P.H., M.D.42.36100000000000-71.0691983000000025636Camargo, CarlosProfessor of Emergency MedicineKH95KoheiHasegawaKohei Hasegawa, M.D.42.33510370000000-71.1061649000000051185Hasegawa, KoheiProfessor of Emergency MedicineAMS5AnneStackAnne Marie Stack, M.D.42.33743600000000-71.1054470000000055422Stack, AnneAssociate Professor of PediatricsTML9TanyaLaidlawTanya Maria Laidlaw, M.D.42.33510370000000-71.1061649000000021068Laidlaw, TanyaAssociate Professor of MedicineWP3WandaPhipatanakulWanda Phipatanakul, M.D.42.33743600000000-71.1054470000000064109Phipatanakul, WandaS. Jean Emans, MD, Professor of Pediatricstrue1Professor of MedicineProfessor of MedicineAuthorship 2075748Allergy and Clinical Immunologytrue1Associate Professor of MedicineAssociate Professor of Medicine34530019Hvisdas C, Louisias M, Laidlaw TM, Akenroye AThe Journal of allergy and clinical immunologyAddressing disparities in biologic drug development in the United States. J Allergy Clin Immunol. 2021 11; 148(5):1154-1156.J Allergy Clin Immunol2021-09-13T00:00:002021Addressing disparities in biologic drug development in the United States.35772597Akenroye A, Lassiter G, Jackson JW, Keet C, Segal J, Alexander GC, Hong HThe Journal of allergy and clinical immunologyComparative efficacy of mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis. J Allergy Clin Immunol. 2022 Nov; 150(5):1097-1105.e12.J Allergy Clin Immunol2022-06-27T00:00:002022Comparative efficacy of mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis.Authorship 14694941Authorship 14694952Authorship 14694964Authorship 14694973Authorship 14694981Authorship 14694991Authorship 14695001Authorship 14695011Authorship 14695021Authorship 14695031Authorship 14695041Authorship 14695051Authorship 14695061Authorship 14695072Authorship 14695081Authorship 14695091Authorship 14695106Authorship 14695111Authorship 14695121Authorship 14695131Authorship 1469514305/2011Harvard T.H. Chan School of Public HealthBoston, MAHarvard T.H. Chan School of Public Health, Public HealthMPHPublic Health27888028Iammatteo M, Ferastraoaru D, Koransky R, Alvarez-Arango S, Thota N, Akenroye A, Jerschow EThe journal of allergy and clinical immunology. In practiceIdentifying Allergic Drug Reactions Through Placebo-Controlled Graded Challenges. J Allergy Clin Immunol Pract. 2017 May - Jun; 5(3):711-717.e2.J Allergy Clin Immunol Pract2016-11-23T00:00:002016Identifying Allergic Drug Reactions Through Placebo-Controlled Graded Challenges.28366583Akenroye AT, Iammatteo M, de Vos GSAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & ImmunologyHyper-immunoglobulin E-like syndrome in a patient with multiple genetic mutations. Ann Allergy Asthma Immunol. 2017 May; 118(5):643-644.Ann Allergy Asthma Immunol2017-03-30T00:00:002017Hyper-immunoglobulin E-like syndrome in a patient with multiple genetic mutations.29733981Akenroye AT, McEwan C, Saini SSThe journal of allergy and clinical immunology. In practiceMontelukast reduces symptom severity and frequency in patients with angioedema-predominant chronic spontaneous urticaria. J Allergy Clin Immunol Pract. 2018 Jul - Aug; 6(4):1403-1405.J Allergy Clin Immunol Pract2018-05-05T00:00:002018Montelukast reduces symptom severity and frequency in patients with angioedema-predominant chronic spontaneous urticaria.28396110Iammatteo M, Akenroye A, Jariwala S, Lee B, Schairer D, Rosenstreich DThe journal of allergy and clinical immunology. In practiceSevere contact dermatitis due to ethylenediamine dihydrochloride in nystatin cream. J Allergy Clin Immunol Pract. 2017 Sep - Oct; 5(5):1448-1450.J Allergy Clin Immunol Pract2017-04-07T00:00:002017Severe contact dermatitis due to ethylenediamine dihydrochloride in nystatin cream.30093380Akenroye AT, Ajala A, Azimi-Nekoo E, de Vos GSEmergency medicine journal : EMJPrevalence of anaphylaxis among adults admitted to critical care for severe asthma exacerbation. Emerg Med J. 2018 Oct; 35(10):623-625.Emerg Med J2018-08-09T00:00:002018Prevalence of anaphylaxis among adults admitted to critical care for severe asthma exacerbation.28120605Akenroye AT, Madan N, Mohammadi F, Leider JEuropean annals of allergy and clinical immunologyHemophagocytic Lymphohistiocytosis mimics many common conditions: case series and review of literature. Eur Ann Allergy Clin Immunol. 2017 Jan; 49(1):31-41.Eur Ann Allergy Clin Immunol2017-01-01T00:00:002017Hemophagocytic Lymphohistiocytosis mimics many common conditions: case series and review of literature.33713768Akenroye AT, Brunetti T, Romero K, Daya M, Kanchan K, Shankar G, Chavan S, Preethi Boorgula M, Ampleford EA, Fonseca HF, Hawkins GA, Pitangueira Teixeira HM, Campbell M, Rafaels N, Winters A, Bleecker ER, Cruz AA, Barreto ML, Meyers DA, Ortega VE, Figueiredo CA, Barnes KC, Checkley W, Hansel NN, Mathias RAThe Journal of allergy and clinical immunologyGenome-wide association study of asthma, total IgE, and lung function in a cohort of Peruvian children. J Allergy Clin Immunol. 2021 12; 148(6):1493-1504.J Allergy Clin Immunol2021-03-10T00:00:002021Genome-wide association study of asthma, total IgE, and lung function in a cohort of Peruvian children.28299109Akenroye OO, Adebona OT, Akenroye ATJournal of public health in AfricaSurgical Care in the Developing World-Strategies and Framework for Improvement. J Public Health Afr. 2013 Dec 03; 4(2):e20.J Public Health Afr2013-12-03T00:00:002013Surgical Care in the Developing World-Strategies and Framework for Improvement.31866437Akenroye A, McCormack M, Keet CThe Journal of allergy and clinical immunologySevere asthma in the US population and eligibility for mAb therapy. J Allergy Clin Immunol. 2020 04; 145(4):1295-1297.e6.J Allergy Clin Immunol2019-12-19T00:00:002019Severe asthma in the US population and eligibility for mAb therapy.31472296Akenroye A, Keet CThe journal of allergy and clinical immunology. In practiceUnderrepresentation of blacks, smokers, and obese patients in studies of monoclonal antibodies for asthma. J Allergy Clin Immunol Pract. 2020 02; 8(2):739-741.e6.J Allergy Clin Immunol Pract2019-08-28T00:00:002019Underrepresentation of blacks, smokers, and obese patients in studies of monoclonal antibodies for asthma.35156624Tariq A, Akenroye A, Azar A, Seo P, Geetha DEuropean journal of rheumatologyRituximab-associated hypogammaglobulinemia in ANCA-associated vasculitis: Incidence and time course. Eur J Rheumatol. 2022 Apr; 9(2):93-99.Eur J Rheumatol2022-04-01T00:00:002022Rituximab-associated hypogammaglobulinemia in ANCA-associated vasculitis: Incidence and time course.32387535Akenroye AT, Wood R, Keet CAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & ImmunologyAsthma, biologics, corticosteroids, and coronavirus disease 2019. Ann Allergy Asthma Immunol. 2020 07; 125(1):12-13.Ann Allergy Asthma Immunol2020-05-06T00:00:002020Asthma, biologics, corticosteroids, and coronavirus disease 2019.33556592Akenroye AT, Heyward J, Keet C, Alexander GCThe journal of allergy and clinical immunology. In practiceLower Use of Biologics for the Treatment of Asthma in Publicly Insured Individuals. J Allergy Clin Immunol Pract. 2021 11; 9(11):3969-3976.J Allergy Clin Immunol Pract2021-02-06T00:00:002021Lower Use of Biologics for the Treatment of Asthma in Publicly Insured Individuals.34293503Wu TD, Fawzy A, Akenroye A, Keet C, Hansel NN, McCormack MCThe journal of allergy and clinical immunology. In practiceMetformin Use and Risk of Asthma Exacerbation Among Asthma Patients with Glycemic Dysfunction. J Allergy Clin Immunol Pract. 2021 11; 9(11):4014-4020.e4.J Allergy Clin Immunol Pract2021-07-19T00:00:002021Metformin Use and Risk of Asthma Exacerbation Among Asthma Patients with Glycemic Dysfunction.33667478Akenroye AT, Keet CAThe Journal of allergy and clinical immunologyMentoring into productivity during fellowship: A working tripartite model. J Allergy Clin Immunol. 2021 05; 147(5):1627-1628.J Allergy Clin Immunol2021-03-02T00:00:002021Mentoring into productivity during fellowship: A working tripartite model.27390217Akenroye AT, Kumthekar AA, Alevizos MK, Mowrey WB, Broder AArthritis care & researchImplementing an Electronic Medical Record-Based Reminder for Cardiovascular Risk Screening in Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2017 05; 69(5):625-632.Arthritis Care Res (Hoboken)2017-04-10T00:00:002017Implementing an Electronic Medical Record-Based Reminder for Cardiovascular Risk Screening in Rheumatoid Arthritis.32859352Akenroye AT, Wood R, Keet CAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & ImmunologyAuthors' response. Ann Allergy Asthma Immunol. 2020 09; 125(3):362.Ann Allergy Asthma Immunol2020-09-01T00:00:002020Authors' response.08/2022Johns Hopkins Bloomberg School of Public HealthBaltimore, MDJohns Hopkins Bloomberg School of Public Health, EpidemiologyPhDEpidemiologytan989TanawinNopsoponTanawin Nopsopon, M.D.196551Nopsopon, TanawinResearch Fellow in Medicine Allergy and immunology03/2008Obafemi Awolowo UniversityIle-Ife, NigeriaObafemi Awolowo University, MedicineMBChBMedicinePrincipal InvestigatorAuthorship 147090912022-11-30AKENROYE, AYOBAMI T2020-12-26Synthesizing Trial and Real-world Data on the Use of Biologics in Patients with Severe Asthma1K99MD015767-0136286487Akenroye A, Zhou G, Jackson JW, Segal J, Alexander GC, Singh SAllergyIncidence of adverse events prompting switching between biologics among adults with asthma: A retrospective cohort study. Allergy. 2023 04; 78(4):1116-1119.Allergy2022-11-05T00:00:002022Incidence of adverse events prompting switching between biologics among adults with asthma: A retrospective cohort study.Authorship 1504147136384205Akenroye A, Ryan T, McGill A, Zhou G, Shier J, Segal JThe journal of allergy and clinical immunology. In practiceSwitch patterns in a cohort of individuals with asthma who received omalizumab or mepolizumab therapy. J Allergy Clin Immunol Pract. 2023 03; 11(3):946-948.e1.J Allergy Clin Immunol Pract2022-11-13T00:00:002022Switch patterns in a cohort of individuals with asthma who received omalizumab or mepolizumab therapy.Authorship 1511298736538979Nopsopon T, Lassiter G, Chen ML, Alexander GC, Keet C, Hong H, Akenroye AThe Journal of allergy and clinical immunologyComparative efficacy of tezepelumab to mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis. J Allergy Clin Immunol. 2023 03; 151(3):747-755.J Allergy Clin Immunol2022-12-17T00:00:002022Comparative efficacy of tezepelumab to mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis.Principal Investigator2025-12-31AKENROYE, AYOBAMI T2023-01-01Synthesizing Trial and Real-world Data on the Use of Biologics in Patients with Severe Asthma4R00MD015767-03Authorship 1521506336716995Chen ML, Nopsopon T, Akenroye AThe journal of allergy and clinical immunology. In practiceIncidence of Anti-Drug Antibodies to Monoclonal Antibodies in Asthma: A Systematic Review and Meta-Analysis. J Allergy Clin Immunol Pract. 2023 05; 11(5):1475-1484.e20.J Allergy Clin Immunol Pract2023-01-28T00:00:002023Incidence of Anti-Drug Antibodies to Monoclonal Antibodies in Asthma: A Systematic Review and Meta-Analysis.Authorship 1522578136740144Akenroye AT, Segal JB, Zhou G, Foer D, Li L, Alexander GC, Keet CA, Jackson JWThe Journal of allergy and clinical immunologyComparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: A target trial emulation. J Allergy Clin Immunol. 2023 05; 151(5):1269-1276.J Allergy Clin Immunol2023-02-03T00:00:002023Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: A target trial emulation.true1Assistant Professor of MedicineAssistant Professor of Medicinehttps://druguselab.bwh.harvard.edu/Drug Utilization, Safety, & Effectiveness (USE) LabAuthorship 1570828137492923Akenroye A, Phipatanakul WPediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and ImmunologyEditorial comment on "Cost-effectiveness of omalizumab for the treatment of severe pediatric allergic asthma-Results of a real-life study in Spain". Pediatr Allergy Immunol. 2023 07; 34(7):e13980.Pediatr Allergy Immunol2023-07-01T00:00:002023Editorial comment on "Cost-effectiveness of omalizumab for the treatment of severe pediatric allergic asthma-Results of a real-life study in Spain".Authorship 1582847237747752Eigenmann P, Akenroye A, Atanaskovic Markovic M, Candotti F, Ebisawa M, Genuneit J, Kalayci Ö, Kollmann D, Leung ASY, Peters RL, Riggioni CPediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and ImmunologyPediatric Allergy and Immunology (PAI) is for polishing with artificial intelligence, but careful use. Pediatr Allergy Immunol. 2023 09; 34(9):e14023.Pediatr Allergy Immunol2023-09-01T00:00:002023Pediatric Allergy and Immunology (PAI) is for polishing with artificial intelligence, but careful use.true1Research Fellow in Medicine Allergy and immunologyResearch Fellow in Medicine Allergy and immunologyAuthorship 1602493137877851Akenroye A, Kalayci Ö, Eigenmann PPediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and ImmunologyFrom preschool wheezing to asthma: Determinants. Pediatr Allergy Immunol. 2023 10; 34(10):e14040.Pediatr Allergy Immunol2023-10-01T00:00:002023From preschool wheezing to asthma: Determinants.Authorship 16118341Authorship 1609720238057814Akenroye A, Nopsopon T, Cho L, Moll M, Weiss STRespiratory researchLower myostatin and higher MUC1 levels are associated with better response to mepolizumab and omalizumab in asthma: a protein-protein interaction analyses. Respir Res. 2023 Dec 06; 24(1):305.Respir Res2023-12-06T00:00:002023Lower myostatin and higher MUC1 levels are associated with better response to mepolizumab and omalizumab in asthma: a protein-protein interaction analyses.37951413Maldonado-Puebla M, Akenroye A, Busby J, Cardet JC, Louisias MThe journal of allergy and clinical immunology. In practicePharmacoequity in Allergy-Immunology: Disparities in Access to Medications for Allergic Diseases and Proposed Solutions in the United States and Globally. J Allergy Clin Immunol Pract. 2024 02; 12(2):272-280.J Allergy Clin Immunol Pract2023-11-10T00:00:002023Pharmacoequity in Allergy-Immunology: Disparities in Access to Medications for Allergic Diseases and Proposed Solutions in the United States and Globally.Authorship 1616809538146114Kamga A, Manca E, Caimmi D, Eigenmann P, Akenroye APediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and ImmunologyEditorial comment on: "Developing a prediction model of children's asthma risk using population-based family history health records". Pediatr Allergy Immunol. 2023 Dec; 34(12):e14063.Pediatr Allergy Immunol2023-12-01T00:00:002023Editorial comment on: "Developing a prediction model of children's asthma risk using population-based family history health records".Authorship 1618240638164813Nopsopon T, Barrett NA, Phipatanakul W, Laidlaw TM, Weiss ST, Akenroye AAllergyLung function trajectories in a cohort of patients with moderate-to-severe asthma on mepolizumab, omalizumab, or dupilumab. Allergy. 2024 Jan 02.Allergy2024-01-02T00:00:002024Lung function trajectories in a cohort of patients with moderate-to-severe asthma on mepolizumab, omalizumab, or dupilumab.true1Professor of Emergency MedicineProfessor of Emergency MedicineAuthorship 1634108138431251Akenroye A, Marshall J, Simon AL, Hague C, Costa R, Jamal-Allial A, McMahill-Walraven CN, Haffenreffer K, Han A, Wu ACThe journal of allergy and clinical immunology. In practiceSmaller differences in the comparative effectiveness of biologics in reducing asthma-related hospitalizations compared to overall exacerbations. J Allergy Clin Immunol Pract. 2024 Feb 29.J Allergy Clin Immunol Pract2024-02-29T00:00:002024Smaller differences in the comparative effectiveness of biologics in reducing asthma-related hospitalizations compared to overall exacerbations.true1Associate Professor of PediatricsAssociate Professor of Pediatricstrue1Professor of Emergency MedicineProfessor of Emergency Medicinetrue1S. Jean Emans, MD, Professor of PediatricsS. Jean Emans, MD, Professor of Pediatricstrue1Professor of MedicineProfessor of MedicineAuthorship 699793124324000Akenroye AT, Baskin MN, Samnaliev M, Stack AMPediatricsImpact of a bronchiolitis guideline on ED resource use and cost: a segmented time-series analysis. Pediatrics. 2014 Jan; 133(1):e227-34.Pediatrics2013-12-09T00:00:002013Impact of a bronchiolitis guideline on ED resource use and cost: a segmented time-series analysis.Emergency Medicine25338705Akenroye AT, Thurm CW, Neuman MI, Alpern ER, Srivastava G, Spencer SP, Simon HK, Tejedor-Sojo J, Gosdin CH, Brennan E, Gottlieb LM, Gay JC, McClead RE, Shah SS, Stack AMJournal of hospital medicinePrevalence and predictors of return visits to pediatric emergency departments. J Hosp Med. 2014 Dec; 9(12):779-87.J Hosp Med2014-10-23T00:00:002014Prevalence and predictors of return visits to pediatric emergency departments.26150121Akenroye AT, Stack AMEmergency medicine journal : EMJThe development and evaluation of an evidence-based guideline programme to improve care in a paediatric emergency department. Emerg Med J. 2016 Feb; 33(2):109-17.Emerg Med J2015-07-06T00:00:002015The development and evaluation of an evidence-based guideline programme to improve care in a paediatric emergency department.2Assistant Professor1Associate Professor6Fellow or Post Doc0Full Professor75 Francis StBrigham and Women's HospitalHBTM 5th floor75 Francis StBoston02115MA